http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018123467-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2018123467-A1 |
titleOfInvention | Novel indoloquinazoline type compound and process for producing the same |
abstract | It is an indoloquinazoline type compound having a specific structure. A clone excellent in AI activity was detected by metagenomic analysis, and a novel indoloquinazoline compound synthase was identified from the clone. The novel indoloquinazoline type compounds have high resistance to microbial degradation and have AI activity. Novel indoloquinazoline type compounds can be used to control the QS mechanism in the fermentation field. This compound can be synthesized biologically and chemically. |
priorityDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.